Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment
Clinical trial NCT04500067 · COMPLETED
Trial details
- NCT number
- NCT04500067
- Sponsor
- Biopharma Plasma LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-07
- Primary completion
- 2020-09-15
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.